Short answer: the brightening shelf has moved from one hero ingredient to a cast of gentler, multi-market actives — azelaic acid leading search growth, tranexamic acid holding steady, kojic acid strong in body formats — and manufacturing each one is a different pH, stability and compliance exercise.
Ingredient-led shopping has reached the tone-and-pigment shelf: buyers now name the molecule they want, and search data shows azelaic acid climbing faster than any other acid while tranexamic and kojic hold their niches. For brands building in this category, each active brings a distinct formulation and compliance profile. Here is the manufacturing view.
The three actives, side by side
| Active | Typical cosmetic range | pH and stability profile | Main formulation challenge |
|---|---|---|---|
| Azelaic acid | ~10% in leave-on formats | Low solubility; needs ester derivatives or suspension technique | Getting real concentration into an elegant texture |
| Tranexamic acid | ~2–5% | Water-soluble, pH-friendly, very stable | Modest potency alone; shines in combination systems |
| Kojic acid | ~1–4% | Oxidation-sensitive; discolouration risk in storage | Stability through shelf life, especially in soap and rinse-off |
None of these is new chemistry — what changed is consumer demand naming them directly, which pushes brands toward honest concentrations and documentable function. That is a manufacturing-friendly trend: these actives reward good process discipline and punish shortcuts visibly.
Azelaic acid: the solubility problem
Azelaic acid is the category's current leader and its most technically awkward raw material. The acid itself is barely soluble in typical cosmetic phases, so real products take one of three routes:
- The ester route — a derivative with far better solubility and sensory, at the cost of being a different molecule with its own positioning.
- Suspension technique — finely dispersed azelaic acid in a purpose-built gel network; the classic "grainy but effective" texture that modern versions have refined considerably.
- Combination systems — lower azelaic levels supported by niacinamide or other tone actives, trading headline concentration for texture.
The manufacturing tell of a good azelaic product is uniformity: the suspension must stay evenly dispersed through filling, shelf life and temperature cycling, which makes dispersion process and stability testing the two checkpoints that separate serious versions from grainy disappointments.
Tranexamic acid: the system player
Tranexamic acid is the easiest of the three to manufacture — water-soluble, pH-tolerant, stable — and the hardest to sell on its own, because its documented performance comes at moderate concentrations in combination systems. The category pattern: tranexamic as the backbone, paired with niacinamide, azelaic or gentle exfoliants, in serums and targeted spot treatments.
For OEM buyers this makes tranexamic the natural first brightening SKU: low formulation risk, friendly to sensitive-skin positioning, and easy to build as a family (full-face serum plus concentrated spot version) from one base. Its pH compatibility with the rest of a routine also means fewer conflicts in multi-product lines.
Kojic acid: the oxidation fight
Kojic acid carries the strongest body-care momentum of the three — it anchors the popular brightening soap and rinse-off segment — but it is the most fragile: it oxidises and discolours in storage, turning a white base progressively tan. The manufacturing answers, usually combined:
- Stabilized derivatives with better colour retention.
- Antioxidant support and oxygen-minimising processing in the base.
- Packaging that limits light and air — significant in rinse-off formats sold in clear packs.
Discolouration does not necessarily mean the active is gone, but it reads as "spoiled" to a customer, which makes colour stability a commercial requirement, not a cosmetic nicety. Hot-cold cycling and light-exposure checks belong in this product's stability programme by default.
The claims line: the category's real complexity
Brightening is the compliance-heaviest claim in skincare, and the rules differ sharply by market:
- In the US, products claiming to treat hyperpigmentation as a condition drift toward drug territory; cosmetic language describes evening the look of skin tone and reducing the appearance of dark spots. Some legacy lightening actives sit entirely outside cosmetic scope.
- In the EU and much of Asia, the cosmetic/drug boundary sits elsewhere, but claims still need substantiation, and several markets restrict specific actives or concentration ceilings.
The safe pattern across markets: name the active and its documented cosmetic function, describe appearance-level outcomes, and keep the acne-medication and prescription language out of the brief entirely. A formula built on azelaic, tranexamic and kojic at cosmetic ranges with appearance-level claims travels well; the same formula with treatment claims does not. The general US/EU labelling framework and per-market testing and certification routes set the boundary details.
Building the category as a range
The efficient OEM structure for this category is a two-or-three SKU family sharing base systems:
- A daily tone serum — tranexamic-acid-based, sensitive-skin friendly, the family's volume anchor.
- A targeted intensive — azelaic-acid-led, positioned for experienced users andblemish-prone skin.
- A body or rinse-off extension — kojic-acid-based, riding the format's strong search momentum, with colour stability engineered in.
All three share preservation thinking, pack compatibility checks and the claim architecture, so development effort concentrates where it should: dispersion and stability for the azelaic SKU, oxidation control for the kojic one.
FAQ
Q: Which brightening active is easiest to manufacture? A: Tranexamic acid — it is water-soluble, pH-tolerant and stable, and performs best as the backbone of combination systems. Azelaic acid is the most technically demanding (low solubility, suspension technique), and kojic acid needs active oxidation and colour-stability management.
Q: Why does my kojic acid soap turn brown? A: Kojic acid oxidises on exposure to light and air, discolouring the base. It does not always mean the active is depleted, but customers read it as spoilage — so stabilized derivatives, antioxidant support and protective packaging are standard engineering, and hot-cold plus light-exposure cycling should be in the stability programme.
Q: Can I make "brightening" claims on a cosmetic label? A: Appearance-level claims — evening the look of skin tone, reducing the appearance of dark spots — are the compliant pattern in most markets. Claims that treat hyperpigmentation as a medical condition cross into drug territory in the US, and some markets restrict specific lightening actives or set concentration ceilings.
Q: What azelaic acid percentage should a product contain? A: Around 10% is the documented leave-on range that consumer expectations are built on. Achieving it in an elegant texture requires ester derivatives or well-engineered suspension systems — a product whose texture is perfect and whose stated concentration cannot be traced to a real dispersion is the classic warning sign in this category.